Who Owns PTC Therapeutics Stock?
NASDAQ: PTCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 122.83%
- Institutions (% of float)
- 132.53%
- Held by insiders
- 7.31%
- Institutional holders
- 522
- Institutions 92.7%
- Insiders 7.3%
- Public and other 0.0%
Who owns PTC Therapeutics stock?
Institutional investors own about 122.8% of PTC Therapeutics's shares, spread across 522 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.31% of PTCT.
The largest institutional holders are Blackrock Inc. (16.73%), RTW Investments LP (9.28%) and Jupiter Topco LLC (8.67%). Together, the top 10 institutions control 63.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their PTCT positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PTCT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 13.96M | 16.73% | +7.8% |
| RTW Investments LP | 7.75M | 9.28% | 0.0% |
| Jupiter Topco LLC | 7.24M | 8.67% | +100.0% |
| Vanguard Portfolio Management LLC | 4.93M | 5.90% | +2.6% |
| State Street Corporation | 4.60M | 5.51% | +5.8% |
| Wellington Management Group, LLP | 4.13M | 4.95% | +4.7% |
| Vanguard Capital Management LLC | 3.74M | 4.48% | +1.7% |
| Geode Capital Management, LLC | 2.21M | 2.64% | -0.1% |
| Toronto Dominion Bank | 2.17M | 2.60% | -28.4% |
| Westfield Capital Management Co LP | 1.96M | 2.34% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PTCT
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.06M | 6.06% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.64M | 3.16% |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 2.31M | 2.77% |
| iShares Trust-iShares Russell 2000 ETF | 2.11M | 2.53% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.90M | 2.28% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.43M | 1.71% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.10M | 1.31% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 995.58K | 1.19% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 951.39K | 1.14% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 905.25K | 1.08% |
Frequently asked questions
Who is the largest shareholder of PTC Therapeutics?
Blackrock Inc. is the largest institutional shareholder of PTCT, owning 16.73% of shares outstanding (13.96M shares) as of its latest 13F filing.
What percentage of PTC Therapeutics is owned by institutions?
Institutions own about 122.8% of PTCT shares and 132.5% of the public float.
How much of PTC Therapeutics do insiders own?
Insiders, such as officers and directors, own about 7.31% of PTCT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.